S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
AMD Results Are No Reason To Buy Semiconductors... Yet
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
AMD Results Are No Reason To Buy Semiconductors... Yet
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
AMD Results Are No Reason To Buy Semiconductors... Yet
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
AMD Results Are No Reason To Buy Semiconductors... Yet
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Institutions are Buying up Procter & Gamble Shares, Should you?
NYSE:RE

Everest Re Group - RE Price Target & Analyst Ratings

$356.33
+6.64 (+1.90%)
(As of 02/1/2023 12:00 AM ET)
Add
Compare
Today's Range
$346.05
$359.39
50-Day Range
$322.38
$358.95
52-Week Range
$244.57
$361.67
Volume
321,979 shs
Average Volume
258,628 shs
Market Capitalization
$13.96 billion
P/E Ratio
26.61
Dividend Yield
1.90%
Price Target
$369.25

Everest Re Group Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 5 Analyst Ratings

Consensus Analyst Price Target

$369.25
3.63% Upside
High Prediction$408.00
Average Prediction$369.25
Low Prediction$344.00
TypeCurrent
2/2/22 to 2/2/23
1 Month Ago
1/3/22 to 1/3/23
3 Months Ago
11/4/21 to 11/4/22
1 Year Ago
2/2/21 to 2/2/22
Consensus Rating
Moderate Buy
Buy
Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$369.25$351.33$332.33$317.60
Predicted Upside3.63% Upside12.96% Upside15.42% Upside18.47% Upside
Get Everest Re Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for RE and its competitors with MarketBeat's FREE daily newsletter.


RE Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

RE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Everest Re Group Stock vs. The Competition

TypeEverest Re GroupFinance CompaniesS&P 500
Consensus Rating Score
2.80
2.43
2.46
Consensus RatingModerate BuyHoldHold
Predicted Upside3.63% Upside49.94% Upside8.16% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/1/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform
1/19/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$380.00+10.37%
1/18/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$365.00 ➝ $408.00+18.10%
11/22/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$320.00 ➝ $345.00+6.47%
7/12/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$343.00 ➝ $344.00+22.92%
8/16/2021Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$330.00+21.47%
6/18/2021Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
3/28/2021Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$245.00 ➝ $305.00+21.93%
12/8/2020Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$245.00 ➝ $275.00+19.40%
11/10/2020Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$218.00 ➝ $235.00+1.43%
8/10/2020UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$235.00 ➝ $246.00+5.53%
7/6/2020Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$258.00+28.39%
4/2/2020Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$263.00+45.11%
2/12/2020Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold$272.00 ➝ $305.00+4.58%
(Data available from 2/2/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












RE Price Target - Frequently Asked Questions

What is Everest Re Group's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for Everest Re Group stock is Moderate Buy based on the current 1 hold rating and 4 buy ratings for RE. The average twelve-month price prediction for Everest Re Group is $369.25 with a high price target of $408.00 and a low price target of $344.00. Learn more on RE's analyst rating history.

Do Wall Street analysts like Everest Re Group more than its competitors?

Analysts like Everest Re Group more than other Finance companies. The consensus rating for Everest Re Group is Moderate Buy while the average consensus rating for finance companies is Hold. Learn more on how RE compares to other companies.

Is Everest Re Group being downgraded by Wall Street analysts?

Over the previous 90 days, Everest Re Group's stock had 1 downgrade by analysts.

Does Everest Re Group's stock price have much upside?

According to analysts, Everest Re Group's stock has a predicted upside of 14.17% based on their 12-month price targets.

What analysts cover Everest Re Group?

Everest Re Group has been rated by BMO Capital Markets, Morgan Stanley, Raymond James, and Wells Fargo & Company in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:RE) was last updated on 2/2/2023 by MarketBeat.com Staff